INS and type 2 diabetes mellitus: An analysis by Zhang et al of 5034 American patients with T2DM initiating insulins between 2014 and 2017 indicated that 6.5% used one of the newer insulins.27 Although there are substantial differences between the healthcare systems in the US and the Netherlands, the findings in the current study (which is more recent) of 26.0% might reflect increasing uptake over time.